Screening Colonoscopy Updates: What They Mean for Your Practice

Handout

Pdf Summary

The GI Quality Improvement Consortium (GIQuIC) is a clinical data registry developed in 2010 as a collaboration between the American College of Gastroenterology (ACG) and the American Society for Gastrointestinal Endoscopy (ASGE). GIQuIC aims to improve patient outcomes, develop quality improvement initiatives, contribute data for research and guideline development, and report to CMS' Merit-based Incentive Payment System. The registry focuses on measuring quality indicators related to colonoscopy and upper gastrointestinal endoscopy, such as adenoma detection rate, cecal intubation rate, withdrawal time, adequacy of bowel prep, and adherence to colorectal cancer (CRC) screening and surveillance recommendations.<br /><br />The document provides case presentations and discussions by panelists, including Aasma Shaukat, MD, Carol Burke, MD, and Audrey Calderwood, MD, on various CRC screening scenarios. These scenarios include a 45-year-old male referred for further management after positive findings on a FIT test, a 40-year-old female with a family history of uterine cancer inquiring about CRC screening, and a 78-year-old patient with a history of a small adenoma 5 years ago.<br /><br />The panelists discuss guidelines and recommendations related to CRC screening, including the ACG Clinical Guidelines, US Preventive Services Task Force (USPSTF) recommendations, US Multi-Society Task Force (USMSTF) guidelines, and the importance of considering hereditary CRC syndromes. They highlight the role of GIQuIC in improving adherence to screening guidelines and the positive impact of organized screening programs.<br /><br />In the case of the 45-year-old patient referred for further management, the panelists discuss the recommended age to start screening. For the 40-year-old female with a family history of uterine cancer, they emphasize the need to consider hereditary CRC syndromes and recommend evaluating her mother for Lynch syndrome. They also discuss the appropriate timing of colonoscopy surveillance for the 78-year-old patient with a history of a small adenoma and address the potential risks and benefits based on age and comorbidities.<br /><br />Overall, the document provides updates on CRC screening recommendations, the role of GIQuIC in quality improvement, and highlights the importance of considering individual patient factors in decision-making.

Keywords

GIQuIC

clinical data registry

colonoscopy

adenoma detection rate

bowel prep

colorectal cancer screening

hereditary CRC syndromes

ACG Clinical Guidelines

US Preventive Services Task Force

organized screening programs